Remove 2024 Remove Dosage Remove Generic Medicine
article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

The organisation stated, PV (pharmacovigilance) events are generally a reflection of the properties of the active drug substance and the drug product, irrespective of where it is manufactured. The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US.

article thumbnail

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Express Pharma

Fixed-dose combinations (FDCs), which contain two or more active ingredients in a single dosage form, have seen a significant rise in production and usage across the pharmaceutical industry. More recently, in August 2024, another 156 FDCs, including widely used cold and fever medications, were prohibited due to safety concerns.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Shaping the future of India’s pharmaceutical operations

Express Pharma

Over the past decade and more, Indias pharmaceutical sector has become the worlds largest supplier of generic medicines, with exports growing faster than the global average. References BMI, a Fitch solutions company, 2024. Generic Drug Facilities, Sites, and Organization Lists; Department of Science and Technology.

article thumbnail

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

PharmaTech

The company has invested $4 billion in the past 15 years to expand its US operations, which began in 1991, and now has an annual domestic capacity to produce 12 billion finished doses of generic medicines. Hikma Publishes its 2024 Sustainability Report Reinforcing Commitment to Global Access to Medicines. Press Release.

Dosage 59